Literature DB >> 2993666

Different forms of membrane-associated herpes simplex virus glycoproteins induce functionally distinct subsets of herpes simplex virus-specific suppressor T cells.

G Y Ishioka, L I Pizer, J W Moorhead.   

Abstract

Previous studies have shown that two types of virus-specific suppressor T cells (Ts) are induced in mice made tolerant with herpes simplex virus (HSV)-infected spleen cells (SC). One type of Ts blocks the afferent phase of the delayed hypersensitivity response to HSV (Ts-aff), and the other blocks the efferent or effector phase (Ts-eff). In this report we show that the induction requirements for these suppressor populations differ. Injection of SC infected for 6 h with HSV at a multiplicity of infection of 5 or less or treated with heat-inactivated virus induced only Ts-aff. Similar results were seen with SC incubated for 90 min in virus-free preparations containing only viral proteins. In contrast, the Ts-eff population was induced only by SC treated for 6 h with infectious HSV at a multiplicity of infection of 10. Collectively, these data indicate that Ts-aff are induced by adsorbed HSV antigens on SC, whereas Ts-eff are induced by nascent HSV antigens expressed on infected SC. In addition to their induction requirements, the two types of regulatory cells differ in their expression of effector function. Ts-eff but not Ts-aff require a cyclophosphamide-sensitive target cell in the immune recipient for suppressor function. The possible identity of this target cell and the significance of the different induction requirements between the two types of Ts are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993666      PMCID: PMC252468     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  The induction of hapten-specific T cell tolerance by using hapten-modified lymphoid cells. I. Characteristics of tolerance induction.

Authors:  S D Miller; H N Claman
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

Review 2.  Infection of the newborn with herpesvirus hominis.

Authors:  A J Nahmias; C A Alford; S B Korones
Journal:  Adv Pediatr       Date:  1970

3.  Mechanisms of regulation of cell-mediated immunity. II. Induction and suppression of delayed-type hypersensitivity to azobenzenearsonate-coupled syngeneic cells.

Authors:  B A Bach; L Sherman; B Benacerraf; M I Greene
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

4.  A role for macrophages in suppressor cell induction.

Authors:  M Usui; I Aoki; G H Sunshine; M E Dorf
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

5.  Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus.

Authors:  A A Nash; P G Gell
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

6.  Delayed hypersensitivity in mice infected with reovirus. II. Induction of tolerance and suppressor T cells to viral specific gene products.

Authors:  M I Greene; H L Weiner
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity.

Authors:  A A Nash; P G Gell; P Wildy
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

8.  Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.

Authors:  A A Nash; N P Ashford
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

9.  Tolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cells.

Authors:  R D Schrier; L I Pizer; J W Moorhead
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen.

Authors:  M S Sy; S D Miller; J W Moorhead; H N Claman
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.